Claire (Jungyoun) Han, PhD, DNP, ARNP, an Assistant Professor from the College of Nursing and an affiliate of the Center for Healthy Aging, Self-Management and Complex Care is designing and developing artificial intelligence (AI) – based chemotoxicity prediction models for patients that have colorectal cancer at The James Cancer Hospital and Solove Research Institute Gastrointestinal Cancer Center.
“We are in the process of developing these AI/ML-based chemotoxicity prediction models, and the next step is to integrate the model into the EHR-based Clinical Decision Support System (CDSS) in real time,” says Han. “This integration will help identify high-risk groups vulnerable to chemotoxicity, which can lead to treatment noncompliance, cancer recurrence, death, adverse events, emergency room visits, hospitalizations, symptom distress and impaired quality of life. This is the first study of its kind in the colorectal cancer population.”
Han plans to use their Spark Award to support the develop and design of a rapid prototype for a preliminary AI-Based chemotoxicity prediction model integrated into a clinical decision support system (AID-CHEMO) as a cloud-based prototype. “With this support, the Spark Award will enable me to generate a preliminary prototype of the potential AID-CHEMO dashboard, laying the foundation for a larger-scale research and future implementation plans.”
Congratulations to Claire (Jungyoun) Han on receiving a Spark Award and using it to make an impact on how colorectal cancer is treated. If you are interested in applying for a Spark Award, applications are being accepted on a rolling basis until April 15, 2025, or until funds are exhausted. For more information, visit go.osu.edu/spark2025.
Julie Johnson, PharmD, is the Director and Principal Investigator at The Ohio State University Clinical and Translational Science Institute.